Finance

Beta
Lists
BLAU3:BVMF
Blau Farmaceutica SA
R$9.92
0.00%
(0.00) 1D
Jun 12, 5:04:00 PM GMT-3  ·   BRL
All symbols
SymbolPriceChange% Change
Generating top insights for BLAU3...
Open
R$9.96
High
R$10.00
Low
R$9.78
Mkt. cap
2.31B
Avg. vol.
239.75K
Volume
264.80K
Dividend
6.37%
Quarterly dividend
R$0.16
Ex-dividend date
Dec 19, 2025
P/E ratio
9.47
52-wk high
R$11.84
52-wk low
R$8.50
EPS
R$1.05
Shares outstanding
233.21M
No. of employees
2K
Open
R$9.96
High
R$10.00
Low
R$9.78
Mkt. cap
2.31B
Avg. vol.
239.75K
Volume
264.80K
Dividend
6.37%
Quarterly dividend
R$0.16
Ex-dividend date
Dec 19, 2025
P/E ratio
9.47
52-wk high
R$11.84
52-wk low
R$8.50
EPS
R$1.05
Shares outstanding
233.21M
No. of employees
2K
News stories
From sources across the web
About Blau Farmaceutica SA
CEOMarcelo Rodolfo Hahn
Employees1.9K
Founded1987
Headquarters-
SectorBiotechnology
Websiteblau.com
Last report
May 8, 2026
Fiscal period
Q1 2026
EPS / Est. (BRL)
R$0.17 / R$0.24
-29.89%miss
Revenue / Est. (BRL)
434.97M / 437.12M
-0.49%miss
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in BRL
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in BRL
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
464.83M
475.20M
389.36M
434.97M
Cost of goods sold
277.68M
282.46M
235.99M
-
Cost of revenue
277.68M
282.46M
235.99M
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
84.54M
90.17M
100.07M
-
Operating expense
83.40M
101.15M
104.83M
-
Total operating expenses
361.08M
383.61M
340.82M
-
Operating income
103.75M
91.59M
48.54M
-
Other non operating income
40.52M
-
-2.58M
-
EBT including unusual items
91.12M
138.33M
44.19M
-
EBT excluding unusual items
91.12M
138.33M
44.19M
-
Income tax expense
27.94M
32.81M
6.81M
-
Effective tax rate
30.66%
23.72%
15.41%
-
Other operating expenses
-1.14M
10.98M
4.76M
-
Net income
63.35M
104.42M
36.25M
-
Net profit margin
13.63%
21.97%
9.31%
-
Earnings per share
0.28
0.53
-
0.17
Interest and investment income
-
106.52M
9.95M
-
Interest expense
-54.40M
-59.77M
-22.99M
-
Net interest expenses
-54.40M
46.75M
-13.04M
-
Depreciation and amortization charges
-
-
-
-
EBITDA
116.97M
103.32M
62.47M
-
Gain or loss from assets sale
-
-
50.02M
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer